MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Meridian Bioscience Total Inventories 2011-2026 | VIVO
Annual Total Inventories Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 67.8 M | 76.8 M | 61.3 M | 39.6 M | 42 M | 41.5 M | 45.1 M | 35.8 M | 35.5 M | 34.8 M | 31.7 M | 32.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 76.8 M | 31.7 M | 45.4 M |
Quarterly Total Inventories Meridian Bioscience
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72.7 M | 67.8 M | - | 70.9 M | 74.2 M | 76.8 M | 71.8 M | 76.8 M | 67.2 M | 61.3 M | 61.3 M | 61.3 M | 42.8 M | 39.6 M | 39.6 M | 39.6 M | 41.9 M | 42 M | 42 M | 42 M | 43.6 M | 41.5 M | 41.5 M | 41.5 M | 44.7 M | 45.1 M | 45.1 M | 45.1 M | 38.8 M | 35.8 M | 35.8 M | 35.8 M | 34.4 M | 35.5 M | 35.5 M | 35.5 M | 37.7 M | 34.8 M | 34.8 M | 34.8 M | 30.3 M | 31.7 M | 31.7 M | 31.7 M | 33.7 M | 32.7 M | 32.7 M | 32.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 76.8 M | 30.3 M | 45.2 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Bioventus
BVS
|
82.2 M | $ 8.96 | 1.01 % | $ 597 M |  USA |
 |
Aspira Women's Health
AWH
|
316 K | - | -6.19 % | $ 10.5 M | USA |
 |
Castle Biosciences
CSTL
|
8.14 M | $ 25.94 | 0.43 % | $ 721 M | USA |
 |
DexCom
DXCM
|
629 M | $ 68.13 | 2.7 % | $ 26.6 B | USA |
 |
Charles River Laboratories International
CRL
|
299 M | $ 154.1 | 1.4 % | $ 7.64 B | USA |
 |
CareDx, Inc
CDNA
|
26.7 M | $ 17.47 | 0.87 % | $ 931 M | USA |
 |
Guardant Health
GH
|
85.9 M | $ 88.35 | 1.34 % | $ 11.1 B | USA |
 |
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
166 M | $ 103.93 | 0.08 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M |  China |
 |
ICON Public Limited Company
ICLR
|
2.3 M | $ 99.75 | 2.19 % | $ 8.23 B |  Irlanda |
 |
Danaher Corporation
DHR
|
2.49 B | $ 195.49 | 2.14 % | $ 139 B | USA |
 |
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
547 M | $ 122.2 | 2.45 % | $ 19.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
189 M | $ 199.41 | 0.23 % | $ 22.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
279 M | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
830 M | $ 113.82 | 1.78 % | $ 34.6 B | USA |
 |
BioNano Genomics
BNGO
|
13.3 M | $ 1.13 | 1.35 % | $ 1.44 M | USA |
 |
DarioHealth Corp.
DRIO
|
5.06 M | $ 9.02 | 7.13 % | $ 256 M |  Israel |
 |
NeoGenomics
NEO
|
28.6 M | $ 8.31 | 0.85 % | $ 1.06 B | USA |
 |
Neogen Corporation
NEOG
|
191 M | $ 9.26 | 1.59 % | $ 2.01 B | USA |
 |
Lantheus Holdings
LNTH
|
64.7 M | $ 79.31 | 1.03 % | $ 5.35 B | USA |
 |
Pacific Biosciences of California
PACB
|
49.3 M | $ 1.42 | 4.04 % | $ 426 M | USA |
 |
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
1.66 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
387 M | $ 1 219.09 | 1.66 % | $ 25.1 B |  Schweiz |
 |
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | USA |
 |
Invitae Corporation
NVTA
|
30.4 M | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
35.4 M | $ 200.3 | 1.33 % | $ 19.7 B | USA |
 |
OPKO Health
OPK
|
56.8 M | $ 1.2 | 0.42 % | $ 833 M | USA |